{"id":"W1965546738","doi":"10.1023/b:pham.0000041444.06122.8d","title":"Peroxisome Proliferator-Activated Receptor (PPAR)-α: A Pharmacological Target with a Promising Future","year":2004,"lang":"en","type":"review","venue":"Pharmaceutical Research","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":270,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"U.S. Department of Veterans Affairs","keywords":"Peroxisome proliferator-activated receptor; Internal medicine; PPAR agonist; Insulin resistance; Dyslipidemia; Endocrinology; Nuclear receptor; Peroxisome proliferator-activated receptor alpha; Metabolic syndrome; Receptor; Lipid metabolism; Biology; Medicine; Diabetes mellitus; Transcription factor; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.002054472,0.001413994,0.002089699,0.0005865216,0.0006665728,0.0003327129,0.001568842,0.001879411,0.001146144],"category_scores_gemma":[0.0005630599,0.001000119,0.0006352641,0.00198355,0.001026262,0.00003708506,0.0009494498,0.005288887,0.0005084617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009062331,"about_ca_system_score_gemma":0.004307058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006615321,"about_ca_topic_score_gemma":0.000001167297,"domain_scores_codex":[0.9896065,0.002428896,0.001052136,0.002447209,0.001860528,0.002604724],"domain_scores_gemma":[0.9961901,0.0002363407,0.000303736,0.0009128146,0.0008432387,0.001513733],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004670995,0.004000277,0.00008610163,0.03152314,0.005597929,0.0004765328,0.0001936253,0.00002187119,0.5310311,0.0002815917,0.01497026,0.4071465],"study_design_scores_gemma":[0.001509254,0.0009119678,3.020776e-7,0.002613335,0.0002597027,0.0001796793,0.00003921162,0.000006368484,0.1971952,0.00001705738,0.7962654,0.001002484],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0038108,0.9891564,0.0000617938,0.0004099833,0.0005325525,0.004984008,0.0002694105,0.0001838113,0.0005912866],"genre_scores_gemma":[0.002312338,0.9879681,0.00148153,0.0001788456,0.0036854,0.002291741,0.001058185,0.000418208,0.000605612],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7812951,"threshold_uncertainty_score":0.999861,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1271914017369632,"score_gpt":0.4588999292057641,"score_spread":0.3317085274688009,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}